Most Recent
Keybridge must contribute to director’s ‘substantial’ legal bill
Investment firm Keybridge must contribute to a director's "substantial" legal bill from a dispute with another director, with a judge finding there was no “lack of clean hands” that would prevent him from being indemnified.
Female-only app appeals discrimination win for trans woman
Female-only app Giggle for Girls has appealed a ruling that found it discriminated against a trans woman by barring her from the app.
‘Dead by Daylight’ game maker defeats rival’s trade mark
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
Medibank admits lack of multi-factor authentication partly to blame for breach
Medibank has denied breaching privacy rules in response to the regulator's case over a 2022 cyber attack, but has admitted sensitive data was hacked in part because its network lacked multi-factor authentication. 
Westpac unit RAMS flags fraud claim in franchisee class action
Westpac's shuttered home loan unit RAMS may hit back at franchisees' class action claims by alleging they made misrepresentations and provided fraudulent documents.
Dentons, Australia chair say ex-partner’s suit in breach of settlement
Dentons and Australian chair Doug Stipanicev have hit back at allegations by a former property partner that they breached workplace laws, saying the partner is barred from bringing his case.
Brookfield sacked manager on maternity leave for seeking flex work, suit says
A former senior manager at Brookfield Properties has claimed she was sacked for taking parental leave and requesting flexible work, but the firm has said a market downturn made her redundant.
Sigma tries to ease concerns over $8.8B Chemist Warehouse tie-up
Drug supplier Sigma Healthcare has offered an undertaking in a bid to allay the competition regulator's concerns about its proposed merger with Chemist Warehouse. 
Vaccine developer loses ‘life and death’ fight with university
A vaccine developer cannot prevent Flinders University from blocking his access to a research lab and interfering with the supply of mice for research relating to COVID-19 and other diseases. 
Liquidators settle with Grant Thornton, Moore Stephens over Linchpin audits
Linchpin Capital liquidators have resolved their case against Grant Thornton and Moore Stephens, a year after a court found the evidence on its face established a claim against the auditors.